Back

Impact of baseline characteristics on efficacy of cilostazol for patients performing endovascular therapy for femoropopliteal lesions

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Peripheral artery disease : endovascular treatment Intervention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Seiichi Hiramori

Kokura Memorial Hospital, Kitakyushu (Japan)

9 More presentations in this session

Presentation thumbnail
Outcome of spot versus full-coverage nitinol stenting after endovascular therapy for femoropopliteal artery disease
Doctor Y. Tomoi (Kitakyushu, JP)
Abstract
Presentation thumbnail
Clopidorel-based antiplatelet therapy is not enough for stent patency in patients undergoing femoropopliteal arterial endovascular interventions.
Doctor K. Higashi (Kagoshima, JP)
Abstract Slides
Presentation thumbnail
Long term usefulness of target lesion revascularization for asymptomatic restenosis of superficial femoral artery after endovascular therapy
Doctor M. Utsunomiya (Tokyo, JP)
Abstract
Presentation thumbnail
Comparison of transradial vs transfemoral access for iliac, femoral, and popliteal interventions. A single-center experience
Associate Professor Z. Ruzsa (Szeged, HU)
Abstract Slides
Presentation thumbnail
Predictive value of vessel size for the long-term patency following self-expanding nitinol stent implantation in the superficial femoral artery
Doctor K. Miki (Nishinomiya, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Peripheral artery disease : endovascular treatment

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources